Soy isoflavones for the treatment of cocaine use disorder: an open-label pilot study.
- 2025-12-23
- Clinical Trial
- Adicciones 37(4)
- Roser Martínez-Riera
- Francina Fonseca
- Rafael De La Torre
- Nieves Pizarro
- Liliana Galindo
- Joan Ignasi Mestre-Pinto
- Magí Farré
- Marta Torrens
- PubMed: 41557447
- DOI: 10.20882/adicciones.2428
- Moderate evidence
- Clinical
The Severity Dependence Scale (SDS) score showed a significant decrease between baseline to 12 weeks, baseline to 16 weeks and 12 to 16 weeks
- Effect
- Beneficial
- Effect size
- Small
- Significant
- Yes